NCT04876898

Brief Summary

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels on admission: overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2, 35-39.9 kg/m2, 40-44.9 kg/m2, and ≥45 kg/m2).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

7 months

First QC Date

May 3, 2021

Last Update Submit

May 3, 2021

Conditions

COVID-19 Pneumonia

Outcome Measures

Primary Outcomes (3)

  • pneumonia

    patients percentages

    30 days

  • sever pneumonia

    patients percentages

    30 days

  • ICU admission

    patients percentages

    30 days

Secondary Outcomes (2)

  • length of hospital stay

    30 days

  • clinical complication

    30 days

Interventions

prospective cohort in high body mass index patient with covid 19OTHER

A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

114 adult patients with confirmed COVID-19 were categorized by BMI levels on admission: overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2, 35-39.9 kg/m2, 40-44.9 kg/m2, and ≥45 kg/m2). Pneumonia, severe pneumonia, and ICU admission rate were our primary outcomes, complications, and length of hospital stay was the secondary outcome.

You may qualify if:

  • patients older than 18 years
  • confirmed COVUID 19 infection
  • body mass index more than 25kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gad sayed Gad

Qina, Qena Governorate, 83511, Egypt

Location

Study Officials

  • Gad S Gad, phd

    ass prof ,anesthesia and ICU ,south valley university,Qena .Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ass.prof anesthesia department

Study Record Dates

First Submitted

May 3, 2021

First Posted

May 7, 2021

Study Start

July 1, 2020

Primary Completion

January 30, 2021

Study Completion

February 28, 2021

Last Updated

May 7, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)